London, Ontario – TheNewswire – December 16, 2020 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) continues to gain attention this week as the company shares have reached new levels over the past few days. Dr. Philip Toleikis, President and CEO of Sernova was interviewed earlier this week by Pat Beechinor of MarketRadio.com.
With the continued valuation of it’s Cell Pouch System in the ongoing clinical trial at the University of Chicago, Sernova has positioned itself as a leader in the cell and gene therapy field has continues to garner attention from key players in the industry with continued ongoing discussions with pharma partners.
Click URL below to Play Interview
The hope for a cure
Sernova’s Cell Pouch System TM delivers the promise of a functional cure for Type 1 Diabetes (T1D) – in the home city (London, ON) of Banting House, where 100 years ago, Dr. Frederick Banting begin its work on what has been to date one of the biggest breakthrough in medicine: Insulin.
A century later, Sernova’s Cell Pouch System could revolutionize the current standard of care with its therapeutic solution made of a device, smaller than a business card, and placed deep under a patient’s skin to serve as a natural environment for therapeutic cells and allow for the body to regain its ability to produce needed proteins or hormones.
Sernova’s clinical investigator, Dr. Piotr Witkowski has been invited to share recent developments at the American Society of Transplant Surgeons 21 st Annual State of the Art Winter Symposium were he will present to more than 600 transplant professionals on January 15, 2021.
For further details and media inquiries, please contact:
Mr. Dominic Gray
Sernova Corp
Tel: (519) 858-5126
[email protected]
Forward-Looking Information
This release and associated Podcast may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Although TheNewswire believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward-looking statements. Forward-looking statements, are based on the beliefs, estimates and opinions on the date such statements were made. TheNewswire expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Copyright (c) 2020 TheNewswire – All rights reserved.
Copyright (c) 2020 TheNewswire – All rights reserved.
